Site Search

Heidelberg Engineering Releases New Software for the Spectralis® OCT and Spectralis® HRA+OCT

Vista, California and Heidelberg, Germany-July 25, 2008 - Heidelberg Engineering has released a new software upgrade for the Spectralis® product line.  The version 3.2 upgrade adds new capabilities to both the 2-mode Spectralis OCT and 6-mode Spectralis HRA+OCT versions of the company’s tracking laser tomographer which combines spectral-domain OCT and confocal scanning laser technologies. 

“The upgrade adds four new features which build on our TruTrack™ eye tracking technology,” said Adam Doherty, Product Manager at Heidelberg Engineering.  “These include dynamic selection of reference images for progression analysis, manual adjustment of the layer segmentation lines, improved display options, and expanded printing options.” 

The set reference feature allows the user to select any image in an existing progression series as a reference in order to analyze changes from different time points. This is possible because TruTrack™ eye tracking technology places follow-up scans at precisely the same location thus enabling detection of subtle changes. The segmentation adjustment feature enables doctors to manually mark any layer of the retina for analysis.

In addition, since doctors often want to see fine detail in both the fundus and OCT images the new version is designed so the user can customize the display on the instrument or networked viewing stations. The new printing options provide similar capabilities for hardcopy printouts. 

Heidelberg Engineering has begun shipping the software upgrade to customers at no charge.  For more information visit the company’s new website at http://www.heidelbergengineering.com/

About Heidelberg Engineering GmbH

Headquartered in Heidelberg, Germany, this privately-held company is a leader in light-based medical devices for ophthalmic applications. The company designs, manufactures and markets a variety of diagnostic instruments for application in retina, glaucoma and cornea diseases. U.S. corporate office is located in Vista, California.

 

1